The Mdm2 protein is frequently overexpressed in human non-seminomatous germ cell tumours and transitional carcinoma of the bladder where it may contribute to tolerance of wtp53. Mdm2 forms an autoregulatory feedback loop with p53; the Mdm2 gene is responsive to transactivation by p53 and once synthesized the Mdm2 protein terminates the p53 response. We show here that the topoisomerase poison etoposide, like ultra violet irradiation, inhibits Mdm2 synthesis. Cytotoxic concentrations of etoposide (IC90 for 43 h) result in inhibition of Mdm2 induction at both the RNA and protein level. Rapid apoptosis ensues. Global transcription is not inhibited: p21
waf-1/cip-1 and GADD45 expression increase in a dose dependent manner. Inhibition of Mdm2 synthesis depends on the continuous presence of etoposide, suggesting the DNA damage may prevent transcription. Downregulation of Mdm2 transcript occurs in cells expressing HPV16-E6 suggesting that inhibition of Mdm2 transcription is p53-independent. When cells are treated with a pulse (1 h) of etoposide and reincubated in drug free medium, Mdm2 synthesis commences immediately after damage is repaired (3 h) and the p53 response is attenuated. Induction of apoptosis and loss of clonogenicity are 3 ± 5-fold lower under pulse treatment conditions. This is the ®rst observation of inhibition ofIntroduction Mdm2 overexpression provides an alternative mechanism to inactivate p53 in tumours where there are no mutations in the p53 gene. Mdm2 has been implicated in the pathogenesis of over 40% of human tumours (for review see Haines, 1997) . The mdm2 protooncogene was originally identi®ed as an ampli®ed gene present on episomes (mouse double minute chromosome) in a spontaneously transformed mouse cell line (Fakharzadeh et al., 1991) . Mdm2 was shown to be transforming by enforced overexpression in immortalized NIH3T3 cells, where it induced tumorigenicity (Fakharzadeh et al., 1991) . In human tumours, overexpression of Mdm2 results from either gene ampli®cation (e.g. in soft tissue sarcomas and breast; Oliner et al., 1992) or enhanced transcription and translation (e.g. in testicular germ cell tumours and transitional carcinoma of the bladder; Barbareschi et al., 1995; Fleischhacker et al., 1994; Landers et al., 1997; Lianes et al., 1994; Riou et al., 1995) .
The transforming properties of Mdm2 can be attributed to its interactions with key proteins involved in regulation of cell cycle progression and apoptosis. In common with the DNA tumour viruses, adenovirus and papilloma virus, Mdm2 inactivates both the p53 and Rb tumor suppressor proteins (Levine, 1990; Momand et al., 1992; Oliner et al., 1993; Weinberg, 1993; Xiao et al., 1995) . Mdm2 regulates p53 function through two mechanisms. Firstly, it binds to the transactivation domain of p53 and inhibits the ability of p53 to transactivate target genes Momand et al., 1992; Oliner et al., 1993) . Secondly, it targets p53 for proteosomedependent degradation regulating the extent and duration of the p53 response (Haupt et al., 1997; Kubbutat et al., 1997) . Following induction of p53 by UV irradiation the p53-dependent upregulation of Mdm2 is delayed until activation of p53-dependent target genes such as p21
waf-1/cip-1 and GADD45 are complete. Mdm2 then terminates the p53 response Reinke and Lozano, 1997; Wu and Levine 1997) . Through these activities Mdm2 inhibits both the growth arrest and apoptosis inducing activities of p53 (Chen et al., 1996; Finlay 1993; Haupt et al., 1996; Kondo et al., 1995; Momand et al., 1992; Oliner et al., 1993) . Mdm2 also regulates Rb by protein-protein interactions. Mdm2 can bind to and inactivate the growth inhibitory function of Rb even when superactive pocket mutants (insensitive to kinase inactivation) are employed (Xiao et al., 1995) .
During normal development the Mdm2/p53 interaction is critical and deletion of the mdm2 gene causes lethality in mice carrying a functional p53 gene (Jones et al., 1995; Montes-de-Oca-Luna et al., 1995) . However, the role of Mdm2 in tumour development probably also depends on the p53-independent functions of Mdm2. Patients with sarcomas overexpressing both Mdm2 and p53 have a worse prognosis than those overexpressing p53 alone . Mdm2 can abrogate Rb and p107-induced growth arrest and provide a growth advantage in cells lacking p53 (Dubs-Poterszman et al., 1995) . Moreover, Mdm2 interacts directly with the Sphase promoting transcription factor E2F1 (Martin et al., 1995; Xiao et al., 1995) .
In an earlier study we demonstrated that the p53 of testicular germ cell tumours (TGCT) and transitional cell carcinoma (TCC) of the bladder was transcriptionally active after etoposide treatment (Chresta et al., 1996) . In the clinic these two urological tumours frequently overexpress Mdm2 and this could block p53-mediated apoptosis and cell cycle arrest (Barbareschi et al., 1995; Fleischhacker et al., 1994; Guillou et al., 1996; Riou et al., 1995) . We therefore investigated the p53/Mdm2 autoregulatory feedback loop under control conditions and after etoposide treatment. We report here that Mdm2 was overexpressed in the absence of gene ampli®cation in both TGCT and TCC. Importantly we found that etoposide was able to perturb the p53/Mdm2 feedback loop. Etoposide inhibited Mdm2 expression whilst inducing the expression of other p53 target genes GADD45 and p21
waf-1/cip-1 . De®ning the pathways of Mdm2 overexpression and analysis of the p53/Mdm2 autoregulatory feedback loop provides information which can be used to facilitate restoration of p53 function in human tumours. Figure 1a shows that Mdm2 protein is overexpressed in all testis tumour lines (TGCT) and in a bladder tumour cell lines which has wtp53 (RT4). The Mdm2 levels are 3 ± 13-fold higher in TGCT and RT4 compared to either normal testis or bladder tumour lines with nonfunctional p53 (RT112 and HT1376). India ink staining of the immunoblot shows that the absence of Mdm2 in the normal testis and RT112 and HT1376 is not a product of under loading (there is slight overloading in the normal sample and 833K). The full length 5.5 kb Mdm2 transcript is also relatively highly expressed in the tumour cell lines tolerating wtp53 (TGCT and RT4) compared to those with mutant p53 (RT112 and HT1376) (Figure 1b) . Analysis of Mdm2 gene copy number by Southern blotting showed the Mdm2 gene is not ampli®ed, suggesting upregulation of Mdm2 is at the level of transcription/ translation ( Figure 1c) .
Results

Overexpression of Mdm2 in testicular and bladder tumour cells tolerating wtp53
Regulation of the p53/Mdm2 feedback loop after etoposide treatment
Since overexpression of Mdm2 is known to inhibit the transactivation activity of p53 (see Introduction) and since we have previously shown p53 in TCC and TGCT is transcriptionally active after etoposide treatment it was of interest to determine the eect of etoposide on Mdm2 expression. The two cell lines studied were the TGCT cell line 833K and the TCC cell line RT4 both of which have wtp53 by sequence analysis (deJong et al., 1997; Rieger et al., 1995) . Equitoxic concentrations of etoposide (derived from clonogenic assays) were used in both cell types. In the TGCT cell line the etoposide concentration ranged from 3.3 mM (99% cells viable) to 52 mM (99% cells dead), whereas in the etoposide resistant cell line, RT4, the concentrations ranged from 80 (10% dead) to 240 mM (90% dead).
In 833K testicular tumour cells following continuous treatment with etoposide, p53 protein levels increase by approximately ®vefold at all doses (4 h incubation), whereas stimulation of Mdm2 transcript levels is maximal at a concentration of etoposide that kills only 10% of cells (IC 10 ) and is inhibited above an IC 50 (Figure 2a,b) . The activity of p53 is not inhibited at these high doses as other p53-dependent genes p21
waf-1/ cip-1 and GADD45 show a dose dependent increase (Figure 2c,d ). The expression of the 1 kb Bax transcript and GAPDH is unchanged by drug treatment demonstrating there is not a general down regulation of transcription or degradation of RNA (Figure 2c ). Identical results have been found in another germ cell tumour line (GH).
We extended these studies to include a transitional carcinoma of the bladder cell line in which we have shown p21 upregulation is p53-dependent (Figure 3 ). The concentrations of etoposide required to induce DNA damage and inhibit the colony formation of the chemosresistant bladder tumour cells (RT4) are much higher than those required to result in cell death in the Endogenous Mdm2 and p53 protein levels were determined by Western blotting using 15 mg of whole cell extract, blots were probed with monoclonal Ab D0-1 for p53 and MoAb 2A10 for Mdm2. (b) Mdm2 and GAPDH transcript levels were analysed by Northern blotting using 15 mg of total RNA. Mdm2 was detected using a HindIII fragment of the Mdm2 cDNA which detects nucleotides 578 ± 1462 of the 2.2 kb cDNA (the HindIII fragment was used to avoid c-terminal Alu sequences). A single transcript at 5.5 kb was detected using this probe. However, we cannot rule out the presence of alternative transcripts which have only N-or C-terminal regions of the molecule which would not be detected with this probe (Sigalas et al., 1996) . (c) Southern blotting of 10 mg genomic DNA restricted with EcoRI and probed with the HindIII fragment of Mdm2 cDNA. Loading was found to be equal by ethidium staining. Only two bands were detected due to use of the HindIII fragment probe, these were of the same size and intensity in all lines. All experiments were repeated three times and results are representative TGCT cell lines (Chresta et al., 1996) . However, as can be seen in Figure 2e the eects of etoposide on Mdm2 and other p53-dependent genes are similar. At the lowest dose of etoposide employed, IC 10 (82 mM), Mdm2 upregulation is completely inhibited, whereas p21 and GADD45 are increased 3 ± 4-fold. Treatment of RT4 with IC 50 or above of etoposide resulted in downregulation of Mdm2 relative to control and reduced the upregulation of p21 and GADD45 (Figure 2e ). High dose etoposide (IC 50 or greater) had no eect on GAPDH levels in RT4 suggesting the eects are not a result of general RNA degradation (see Figure 3b ).
Inhibition of Mdm2 expression by etoposide is p53-independent
High dose UV-irradiation (10 and 20 J/m 2 ) similarly results in dierential regulation of Mdm2 and p21; Mdm2 synthesis is delayed until damage is repaired (Reinke and Lozano, 1997; Wu and Levine 1997) . Downregulation of Mdm2 transcript levels in response to high dose UV-irradiation has been attributed to a p53-independent UV responsive repressor of Mdm2 transcription (Wu and Levine 1997) . To investigate if the etoposide eects are also p53-independent, we examined the inhibition of Mdm2 expression in RT4 cells engineered to express human papilloma virus E6 protein. The E6 expressing cells have undetectable levels of p53 protein and fail to upregulate p21 RNA or protein in response to etoposide treatment ( Figure   3a ,b). However, as can be seen in Figure 3b down regulation of Mdm2 by an IC 50 concentration of etoposide was unaected by the presence of E6, demonstrating that the inhibitory eects of etoposide are p53-independent.
Inhibition of Mdm2 transcription is reversible following repair of etoposide-induced DNA damage
Inhibition of Mdm2 by etoposide and UV-irradiation could result from activation of an etoposide/UVresponsive repressor of Mdm2 transcription (Wu and Levine 1997) . Alternatively, etoposide (and possibly UV) may act directly to inhibit transcription. Etoposide is a topoisomerase II (topo II) poison which inhibits the resealing activity of topo II, resulting in a bulky DNA protein complex. The presence of etoposide and UV-induced lesions in DNA can directly impair transcription (Ljungman and Zhang, 1996; Riou et al., 1993) . If the Mdm2 transcription is inhibited by etoposide damage then removal of etoposide, which results in reversal of etoposide topo II complex, should allow transcription to proceed. Figure 4 demonstrates that both the etoposide-induced single strand breaks and the repression of Mdm2 synthesis are readily reversed after drug removal. The levels of Mdm2 RNA and protein are much lower in response to continuous treatment with an IC 10 or IC 90 of etoposide compared to when repair is allowed after pulse treatment (Figure 4b , top panels). Drug removal also results in a decrease in p53 levels, probably as a result of Mdm2 upregulation (Figure 4b , lower panel). The suppression of GADD45 and p21 synthesis seen at high concentrations of etoposide in RT4 is also relieved by drug removal (results not shown). Results shown are for the TGCT 833K cell line, identical ®ndings have been seen in another TGCT cell line (GH).
Rapid activation of the Mdm2 autoregulatory feedback loop after drug removal
The results in Figure 4b demonstrate that when Mdm2 protein is upregulated (following pulse treatment) there is subsequent p53 downregulation. To analyse this further we determined the kinetics of Mdm2 induction and p53 decline following a short pulse treatment with etoposide. In 833K cells p53 is elevated at the 2 h timepoint (immunoblot in Figure  5a ). However, by 4 h, p53 protein levels decrease, coincident with Mdm2 synthesis. Downregulation of p53 at 4 h just precedes downregulation of the p21 waf-1/ cip-1 transcript (Figure 5b ). This suggests the Mdm2 autoregulatory feedback loop rapidly terminates the p53 response after etoposide damage is repaired. As can be seen in Figure 5c the levels of p21 RNA and p53 protein are reduced when cells are pulse treated allowing repair. The transient decrease in Mdm2 protein (but not RNA) at 7 h results from proteolysis by caspases (Erhardt et al., 1997) (Figure 5a ). This timepoint is co-incident with a peak in apoptosis in 833K cells under these conditions. Activation of caspases was con®rmed by an increase in the cleavage product of polyADPribose polymerase (Figure 5a ). The slight decrease in Mdm2 protein at 2 h after drug treatment occurs consistently in 833K and RT4 cells; Analysis of the eects of loss of p53 function on p21 and Mdm2 transcript levels in control and etoposide treated cells (4 h with 96 mM). Transcript levels of Mdm2, p21 and GAPDH were determined as described in legend to Figure 2 it probably results from temporary inhibition of Mdm2 synthesis during the 1 h pulse treatment.
Continuous etoposide treatment prolongs the p53 response and results in rapid apoptosis
DNA damaging agents can activate p53-mediated apoptosis whilst Mdm2 can protect against p53-mediated apoptosis (Chen et al., 1996; Haupt et al., 1996; Kondo et al., 1995) . Since continuous treatment with etoposide both depletes Mdm2 and increases the extent and duration of the p53 response (Figure 5c ), we have determined if this treatment schedule also aects the activation of apoptosis. As can be seen in Figure 6a there is up to 65% increase in apoptosis produced by a 4 h continuous incubation compared to a 1 h short pulse with etoposide. This is not just an alteration in the kinetics of apoptosis as there is also a signi®cant increase in the loss of clonogenicity (long-term survival) (Figure 6b ). Although prolonged etoposide treatment would be expected to kill more cells, the dramatic eect of such a small dierence in treatment time is unusual. For example, in the human leukemia cell lines MOLT-4, where p53 is inactivated by mutation, there is only a 3% increase in apoptotic cells following continuous treament with 50 mM etoposide for 4 h compared to a 1 h pulse treatment ( Figure  6c ).
Mdm-2 expression is dierentially aected by etoposide and the radiomimetic drug bleomycin
Etoposide (and UV) can induce the p53 of ataxia telangiectasia cells (AT) despite the fact it is resistant to induction by other DNA damaging agents such as g-irradiation and bleomycin (Canman et al., 1994) . Potentially, downregulation of Mdm2 by etoposide (this study) and UV may augment p53 upregulation under conditions when the usual signal transduction mechanisms are defective. We therefore determined the eects of Bleomycin on Mdm2 expression in 833K (TGCT) and RT4 (TCC) cells. We demonstrate that Bleomycin (like etoposide) produced DNA strand breaks that were rapidly reversed. Alkaline elution demonstrated that 0.5 mg/ml bleomycin produced 370 and 400 rad equivalent single strand breaks in 833K and RT4 respectively (data not shown). However, in contrast to the ®ndings with etoposide, continuous treatment with an IC90 dose of bleomycin upregulates both p21 and Mdm2 (Figure 7a ). Although bleomycin is an eective inhibitor of colony formation in 833K and RT4 it was found to be a weak inducer of apoptosis (Figure 7b ). Whether the weak activation of apoptosis results from Mdm2 upregulation has yet to be investigated. In contrast to results with etoposide, a 1 or 4 h treatment with waf-1/cip-1 transcript induction in 833K cells. Samples of total RNA or protein were prepared at 3 or 4 h respectively following 1 h pulse or continuous etoposide treatment. p53 protein levels were determined by immunoblotting and scanning densitometry. p21 and GAPDH transcript levels were determined by phospho-image analysis, data presented is normalized to GAPDH bleomycin produced an equivalent level of cell killing measured by colony formation (Figure 7c) .
Discussion
We have previously demonstrated that human testicular (TGCT) and bladder (TCC) tumour cell lines express wtp53 that is activated following etoposide treatment (Chresta et al., 1996) . Tolerance of wtp53 in tumours frequently results from overexpression of Mdm2 (see Introduction; Haines, 1997) . The results presented here demonstrate that Mdm2 is overexpressed in both testicular and bladder carcinoma cells. However, we show that the Mdm2-p53 autoregulatory feedback loop can be inhibited in dosedependent manner by etoposide treatment.
Mdm2 RNA and protein were found to be overexpressed in the full length 5.5 kb and 97 kDa forms in all TGCT and in TCC tolerating wtp53 (Figure 1 ). There was no evidence for ampli®cation of the Mdm2 gene suggesting overexpression of Mdm2 results from upregulation at either the transcriptional or translational level. Mdm2 can be expressed from two distinct promoters, P1 which is p53-independent and P2 which is p53-dependent (Barak et al., 1994) . In the TCC cell line RT4 the endogenous Mdm2 levels were regulated p53-independently (demonstrated using HPV-E6 to target p53 for degradation ± Figure 3b ). This is of interest as expression from the p53-independent promoter has been demonstrated to be regulated by growth factors (Shaulian et al., 1997) . This suggests the possibility that in tumours such as TGCT and TCC aberrant survival signalling pathways could induce overexpression of Mdm2 and hence contribute to tumorigenesis.
Usually, overexpressed Mdm2 blocks p53-activity. This inhibition can be overcome by three mechanisms. Firstly, DNA damaging agents can induce posttranslational modi®cation of p53 which disrupts the Mdm2/p53 interaction (Shieh et al., 1997; Siliciano et al., 1997) . Secondly, inhibition of Mdm2 synthesis by antisense oligonucleotides can activate p53 (Chen et al., 1998) . Thirdly, the p53/Mdm2 complex can be disrupted by physical/steric means using antibodies or mini-proteins (Blaydes et al., 1997; Bottger et al., 1997) .
How does etoposide activate p53 in Mdm2 overexpressing cells? Firstly, topoisomerase poisons, such as etoposide, activate at least two protein kinases which phosphorylate the amino-terminal of p53, casein kinase 1 and DNA protein kinase (Knippschild et al., 1996 (Knippschild et al., , 1997 Shieh et al., 1997; Siliciano et al., 1997) . Phosphorylation in this region has been demonstrated to prevent Mdm2 binding to p53, which should enhance p53 activity (Shieh et al., 1997) . Secondly, inhibition of Mdm2 synthesis by etoposide could synergise with a post-translational activation mechanism to enhance activation of p53. In cells such as TGCT and TCC, that overexpress Mdm2, the post- translational modi®cation activation mechanism may not be able to result in a signi®cant p53-response. Recent studies by Chen et al. (1998) have shown that the DNA damaging agent camptothecin cannot achieve maximal activation of p53 in Mdm2 overexpressing JAR cells, unless Mdm2 synthesis is also inhibited. Our results similarly suggest that etoposide treatment conditions which reduce Mdm2 levels (continuous 4 h) result in higher p53 levels and transcriptional activity (Figure 5c ). Presumably etoposide-induced inhibition of Mdm2 synthesis prevents Mdm2 mediated ubiquitination and proteolysis of p53. Studies comparing UV and g-irradiation demonstrated a prolonged p53 response in response to UV but not girradiation. Interestingly, UV but not g-irradiation, decreases both Mdm2 protein levels and the ubiquitination of p53 (Maki and Howley 1997; Wu and Levine 1997) .
Studies in mouse testicular germ cell tumours (F9) suggest that both post-translational modi®cation and inhibition of Mdm2 synthesis could contribute to activation of p53 by etoposide. Reich et al. (1982) showed that cycloheximide results in stabilization of p53, as a result of downregulation of proteins that control p53 stability (presumably Mdm2). However, the transcriptional activity of p53 was not increased unless the cells were also treated with etoposide (Lutzker and . Further studies with antisense Mdm2 will allow us to determine whether downregulation of Mdm2 facilitates activation of p53 by DNA damaging agents. If Mdm2 antisense can, like etoposide, promote apoptosis in TGCT and TCC cells, then these tumours would be good candidates for treatment using inhibitory mini proteins which disrupt the p53/Mdm2 interaction (Bottger et al., 1997) . The downregulation of Mdm2 by etoposide was unexpected and is in contrast to earlier reports of induction of Mdm2 by the DNA strand breaking agents g-irradiation and bleomycin (Blaydes et al., 1997; Chen et al., 1994; Perry et al., 1993) . However, dierential activation of p21
waf-1/cip-1 and Mdm2 have been reported previously in response to high dose UVirradiation (Blaydes et al., 1997; Lu et al., 1996; Lu and Levine, 1993; Perry et al., 1993; Reinke and Lozano, 1997; Wu and Levine 1997) . UV results in sequential activation of p21
waf-1/cip-1 and Mdm2; this induces cell cycle arrest and allows potential repair synthesis before Mdm2 terminates the p53 response (Lu et al., 1996; Perry et al., 1993; Reinke et al., 1997; Wu and Levine 1997) . Several hypotheses have been put forward to explain the delayed activation of Mdm2 by high dose UV-irradiation. Firstly, Reinke and Lozano (1997) suggest that the higher anity of p53 for the p21
waf-1/cip-1 promoter may result in preferential activation of p21
waf-1/cip-1 before Mdm2 following UVirradiation (10 J/m 2 ). However, we ®nd that low doses of etoposide (IC 10 -7 mM) can result in coincident synthesis of p21
waf-1/cip-1 and Mdm2 RNA suggesting this is not the case for etoposide activated p53 (Figure 2) . Secondly, Lu et al. (1996) proposed that high dose UV may inhibit p53 activity, either directly or indirectly. However, we have shown that p53 activates p21
waf-1/cip-1 and GADD45 under conditions where Mdm2 RNA synthesis is inhibited (Figures 2 and 3) . Therefore an inhibitor of p53 transcriptional activity would have to speci®cally aect the activity of p53 on the Mdm2 promoter. Finally, Wu and Levine (1997) suggest high dose UV-irradiation may induce a p53-independent repressor which is rapidly activated by DNA damage and rapidly inactivated following repair. Our data is consistent with this hypothesis, however, several observations from our work and that of others lead us to suggest an alternative hypothesis; that damage to the DNA template per se (by UV and etoposide) inhibits Mdm2 synthesis.
We suggest that when DNA damage is above a certain threshold Mdm2 synthesis is prevented by bulky adduct damage to the DNA template. This would eectively prevent Mdm2 synthesis until repair had occurred. The speci®city for inhibition of Mdm2 probably occurs because the promoter has altered chromatin conformation. The Mdm2 P1 and P2 promoters are nucleosome free and display constitutive DNAse 1 sensitivity (Xiao et al., 1998) . In addition Mdm2 is a short-half life protein which is very actively transcribed so will be the site of enhanced topoisomerase activity. Similar ®ndings of etoposide hypersensitivity were previously described for DNAse 1 sensitive region in the c-myc gene (Riou et al., 1993) . It is of note that c-myc and mdm2 both form episomes and are frequently ampli®ed in human tumour's suggesting their chromatin conformation may be unusual.
The model of a UV-induced repressor of Mdm2 synthesis is attractive because it suggests temporal control in the activation of p53-dependent genes with dierent function. Delayed activation of Mdm2 allowing p21 to halt cell cycle progression until DNA damage is repaired. However, several pieces of evidence are not consistent with this model. Firstly, when the level of DNA damage produced by either UVirradiation (50 J/m 2 ) or etoposide (490 mM) is high, the speci®city for Mdm2 is lost and both GADD45 and p21 expression are inhibited (Figure 2e ) (Lu et al., 1996; Reinke and Lozano, 1997) . Secondly, Reinke and Lozano (1997) have shown that the p53 from extracts of UV-treated cells (50 J/m 2 ) can still bind to an exogenously added p21 promoter, demonstrating p53 DNA binding activity is not repressed. Thirdly, when we studied the eects of Bleomycin, which produces single and double strand scission by free radical damage, we found that Mdm2 was upregulated without delay. Thus, Mdm2 is induced despite the fact that repair has not taken place and 90% of these cells are destined to die (Figure 7 ). This suggests that the bulky adducts produced by etoposide and UVdamage inhibit Mdm2 synthesis, rather than a repressor activated by high levels of unrepairable damage.
The p53-dependent activation of Mdm2 usually limits the extent and duration of the p53 response after DNA damage Haupt et al., 1997; Kubbutat et al., 1997) . This can be seen in Figure  5 , where downregulation of p53 is coincident with upregulation of Mdm2 4 h after drug treatment. Under these pulse treatment conditions activation of p21
waf-1/cip-1 occurs in the short time window between activation of p53 and further upregulation of Mdm2 (Figure 5b ). Thus, Mdm2 eectively and rapidly terminates the p53 response. In contrast, under conditions of continuous treatment with etoposide Mdm2 upregulation is repressed and the levels of p53 and p21
waf-1/cip-1 remain at maximal levels ( Figure 5c ). Signi®cantly these conditions also result in a dramatic increase in the activation of apoptosis and long-term loss of viability (Figure 6a,b) . Downregulation of Mdm2 by antisense has similarly been demonstrated to enhance camptothecin and cisplatin-induced apoptosis (Chen et al., 1998; Kondo et al., 1995) . This is the ®rst observation of Mdm2 regulation by a topoisomerase II poison. The results are strikingly similar to the eects of high dose UV-irradiation and it is possible that both UV and etoposide activate a repressor of Mdm2 synthesis. However, the rapid reversibility of the etoposide eect suggests Mdm2 expression could be inhibited by bulky adduct damage to the template which eectively maintains the p53 response until repair has taken place.
Materials and methods
Cell culture and cytotoxicity assays
All the cell lines were grown routinely in 25 cm 2¯a sks in RPMI 1640 medium with 10% (v/v) heat inactivated fetal calf serum, 2 mM glutamine, at 378C in a humidi®ed atmosphere of 5% CO 2 in air. Each cell line was used over a maximum of 12 passages to minimize changes that occur during prolonged culture. All cell lines were routinely tested and found to be mycoplasma free. Drug sensitivity was measured by clonogenic assays. One thousand cells were plated per well in 6-well plates (2 cm 2 ) and allowed to adhere overnight. They were then treated for indicated times with etoposide or vehicle control, dimethylsulfoxide. The drug was then washed from the cells with three changes of PBS and the cells reincubated in fresh medium for 10 ± 14 days. Colonies were stained with methylene blue and colonies of greater than 50 cells were counted.
Western blotting
Samples were collected 4 h after either continuous or 1 h pulse drug treatment. Following 4 h continuous drug treatment, apoptotic cells detached from the monolayer. These cells were collected by centrifugation and combined with the monolayer cells which had been detached by scraping into versene (GIBCO BRL, Paisley, Scotland, UK). Cells were rinsed in ice cold PBS containing the following protease inhibitors (PI), aprotinin (1%), benzamidine (1 mM), phenylmethylsulphonyl¯uoride (1 mM), trypsin/chymotrypsin inhibitor (10 mg/ml) (Sigma, Poole, UK) then resuspended in 300 ml of PBS with PI and sonicated using a Soniprep 150 (MSE) for 10 s at 12 microns, allowed to cool, then sonicated again for 10 s at 16 microns. Protein concentration was determined using a BioRad protein assay kit and 15 mg of protein used per sample. Samples were boiled for 5 min in SDS sample buer and then electrophoresed on 0.75 mm polyacrylamide slab gels. Proteins were transferred to Immobilon-P membrane (Millipore, Harrow, UK) at 80 V for 1.5 h.
Southern blotting
Cells (1610 6 ) were washed in PBS then lysed in 250 ml of sarcosyl lysis solution (0.2% sarcosyl, 2 M NaCl, 0.04 M EDTA, pH 10) containing proteinase K at 0.5 mg/ml, the lysate was incubated overnight at 458C, then diluted with one volume of TE buer and DNA precipitated by addition of two volumes of 95% ethanol (7208C). Precipitates were allowed to form at 7208C for 30 min and then collected by centrifugation at 48C. The pellets were washed in 70% ethanol then 95% ethanol, dried and resuspended in TE and restricted overnight with EcoRI prior to electrophoresis. Gels were blotted and probed as described by Maniatis under high stringency conditions (Sambrook et al., 1989) . The probe used for Mdm2 is a HindIII fragment of the human cDNA clone FL4. This region spans nucleotides 578 ± 1462 of the human Mdm2 cDNA.
Northern blotting
Cells were collected as for Western blotting, rinsed in PBS then total RNA was isolated using RNAzol B as described by the manufacturers (Biogenesis). Fifteen mg of total RNA was loaded per lane onto formaldehyde gels and separated overnight. Samples were prepared, electrophoresed and blotted as described by Maniatis. Filters were washed 3 ± 5 times for 15 min with 26SSC; 0.1% SDS at room temperature and for 1 ± 10 min at 658C with 0.26SSC; 0.1% SDS depending upon the probes used.
DNA fragmentation ®lter binding assay (FBA) 2
Apoptosis was quanti®ed using the ®lter binding assay (Bertrand et al., 1991) . Percentage DNA fragmentation assayed using the FBA corresponded well with frequency of cells demonstrating apoptotic morphology by Hoechst 33258 staining.
Alkaline elution
DNA single-strand breaks (SSBs) were measured by alkaline elution (pH 12.1) as described by Kohn et al. (1976) . Cells in early logarithmic phase growth (1 ± 2610 5 / ml) were labelled for 30 h with 0.015 mCi 14 C-thymidine/ml (speci®c activity, 56 mCi/mmol; Amersham, UK), washed and reincubated in fresh medium for 2 h. The cells were then exposed to etoposide for 1 h. Following drug treatment cells were rinsed with ice cold PBS and then scraped into ice cold versene to minimize the possibility of reversal of damage. Cells were collected by centrifugation and resuspended in ice cold PBS. 8610 5 cells were loaded onto each ®lter and rinsed with 10 ml ice-cold PBS before lysis. For measurement of DNA SSBs cells were lysed using a sarcosyl lysis solution (0.2% sodium dodecyl sarcosine; 2 M NaCl; 0.04M EDTA pH 10) onto 2 mm polycarbonate ®lters (Millipore). DNA was eluted for 15 h at 0.04 ml/min with tetraethylammonium hydroxide (pH 12.1) containing 0.1% SDS. DNA remaining on the ®lter and in the ®lter funnels was released as described (Kohn et al., 1976) . The frequency of SSBs induced by etoposide or bleomycin were converted to rad equivalents using a calibration graph derived from the number of SSBs produced by a known Xray dose.
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